Dementia with Lewy bodies.

Glia and alpha-synuclein in neurodegeneration: A complex interaction. Neurobiol Dis (2015) 0.93

Munc18-1 is a molecular chaperone for α-synuclein, controlling its self-replicating aggregation. J Cell Biol (2016) 0.81

Activation of Mitochondrial Complex II-Dependent Respiration Is Beneficial for α-Synucleinopathies. Mol Neurobiol (2015) 0.77

Cognitive and affective theory of mind in dementia with Lewy bodies and Alzheimer's disease. Alzheimers Res Ther (2016) 0.77

Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease. Biomolecules (2015) 0.77

Differential diagnosis of Alzheimer's disease using spectrochemical analysis of blood. Proc Natl Acad Sci U S A (2017) 0.75

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology (1994) 21.65

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33

Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol (2003) 4.76

Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord (2003) 4.56

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet (2000) 4.37

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology (1990) 3.79

Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology (2003) 3.07

Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol (2000) 2.91

Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease? Clin Neuropathol (1985) 2.72

Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann Neurol (2002) 2.70

Dementia with Lewy bodies. Lancet Neurol (2004) 2.66

Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci (1990) 2.24

DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology (2004) 2.12

Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ (1992) 2.12

Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord (2001) 2.00

Dementia associated with Parkinson's disease. Lancet Neurol (2003) 2.00

Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older. J Neurol Neurosurg Psychiatry (2003) 1.90

Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol (1998) 1.80

The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia. Br J Psychiatry (2000) 1.61

High prevalence of neurovascular instability in neurodegenerative dementias. Neurology (1998) 1.59

Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry (1989) 1.57

Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial. Int Psychogeriatr (2001) 1.57

Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med (1992) 1.49

Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain (1987) 1.44

Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology (2002) 1.42

Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology (2001) 1.34

Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol (2004) 1.33

Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia. Neurology (2001) 1.32

Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol (2001) 1.31

Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia. Dement Geriatr Cogn Disord (2003) 1.27

A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. Int J Geriatr Psychiatry (2001) 1.26

Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease. Ann N Y Acad Sci (1991) 1.24

Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology (1999) 1.24

Delusions associated with elevated muscarinic binding in dementia with Lewy bodies. Ann Neurol (2000) 1.20

Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system. Dement Geriatr Cogn Disord (2002) 1.20

MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementia. Neurology (2000) 1.19

A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. Eur J Nucl Med Mol Imaging (2002) 1.19

Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology (1999) 1.16

Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study. J Neurol Neurosurg Psychiatry (2002) 1.16

Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. Neurology (2000) 1.14

Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria. Neurology (1996) 1.13

Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease. Lancet (1998) 1.11

Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample. Int J Geriatr Psychiatry (1999) 1.11

Neuropsychological performance in Lewy body dementia and Alzheimer's disease. Br J Psychiatry (1997) 1.05

Fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease is qualitatively distinct. J Neurol Neurosurg Psychiatry (2004) 1.05

The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease. Int J Geriatr Psychiatry (2001) 1.02

Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: A cross-sectional comparative study. Mov Disord (2003) 1.01

Neocortical lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. J Neuropathol Exp Neurol (1996) 0.96

Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study. Int J Geriatr Psychiatry (2000) 0.95

Dementia with Lewy bodies: diagnosis and management. Int J Geriatr Psychiatry (2001) 0.95

Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease. J Neuropsychiatry Clin Neurosci (2001) 0.94

Predictors of progression in patients with AD and Lewy bodies. Neurology (2000) 0.94

What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia. Int J Geriatr Psychiatry (2003) 0.93

A comparison of sleep profiles in patients with dementia with lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry (2000) 0.92

MRI volumetric correlates of white matter lesions in dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry (2000) 0.92

Cardiovascular effects of donepezil in patients with dementia. Dement Geriatr Cogn Disord (2003) 0.91

Rapidly progressive dementia in a patient with the Lewy body variant of Alzheimer's disease. Neurology (1991) 0.90

Dementia with Lewy bodies: response of delirium-like features to donepezil. Neurology (1998) 0.89

In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies. Lancet (1999) 0.87

Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies. Dement Geriatr Cogn Disord (2004) 0.87

One year follow-up of parkinsonism in dementia with Lewy bodies. Dement Geriatr Cogn Disord (2000) 0.86

Three years survival in patients with a clinical diagnosis of dementia with Lewy bodies. Int J Geriatr Psychiatry (2000) 0.85

Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Alzheimer Dis Assoc Disord (1990) 0.82

Temporal pattern of cognitive decline and incontinence is different in Alzheimer's disease and diffuse Lewy body disease. Neurology (1996) 0.81

Dementia with Lewy bodies: improving diagnostic criteria. Neurology (2003) 0.79

Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease. Mov Disord (2003) 0.79

Dementia with Lewy bodies and other difficult diagnoses. Int Psychogeriatr (2004) 0.76